Last updated on July 2019

A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes


Brief description of study

The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease. Participants will either get semaglutide tablets or placebo tablets ("dummy" medicine) - which treatment is decided by chance. Participants must take one tablet with water every morning on an empty stomach and not eat or drink anything for at least 30 minutes. The study will last for about 3.5-5 years. Participants will have up to 25 clinic visits and 1 phone call with the study doctor. Women cannot be in the study if pregnant, breast-feeding or if they plan to become pregnant during the study period.

Clinical Study Identifier: NCT03914326

Find a site near you

Start Over

Novo Nordisk Investigational Site

Little Rock, AR United States
  Connect »

Novo Nordisk Investigational Site

Los Alamitos, CA United States
  Connect »

Novo Nordisk Investigational Site

Palm Springs, CA United States
  Connect »

Novo Nordisk Investigational Site

New Port Richey, FL United States
  Connect »

Novo Nordisk Investigational Site

Lawrenceville, GA United States
  Connect »

Novo Nordisk Investigational Site

Idaho Falls, ID United States
  Connect »

Novo Nordisk Investigational Site

West Des Moines, IA United States
  Connect »

Novo Nordisk Investigational Site

West Seneca, NY United States
  Connect »

Novo Nordisk Investigational Site

Chapel Hill, NC United States
  Connect »

Novo Nordisk Investigational Site

Murrells Inlet, SC United States
  Connect »

Novo Nordisk Investigational Site

Myrtle Beach, SC United States
  Connect »

Novo Nordisk Investigational Site

Spartanburg, SC United States
  Connect »

Novo Nordisk Investigational Site

Chattanooga, TN United States
  Connect »

Novo Nordisk Investigational Site

San Nicolas de los Garza, Mexico
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.